Véronique Dartois Selected Research

Isoniazid (Ftivazide)

1/2023	The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability.
1/2022	CinA mediates multidrug tolerance in Mycobacterium tuberculosis.
1/2020	A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA.
2/2016	Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model.
11/2015	In silico evaluation and exploration of antibiotic tuberculosis treatment regimens.
1/2012	Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.
5/2010	Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Véronique Dartois Research Topics

Disease

59	Tuberculosis (Tuberculoses) 04/2024 - 05/2010
33	Infections 04/2024 - 08/2005
19	Granuloma 04/2024 - 03/2011
10	Lung Diseases (Lung Disease) 05/2024 - 07/2015
5	Inflammation (Inflammations) 01/2020 - 02/2016
4	Communicable Diseases (Infectious Diseases) 02/2023 - 01/2020
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 01/2019
3	Pulmonary Tuberculosis 01/2021 - 02/2016
2	Hypoxia (Hypoxemia) 02/2024 - 01/2022
2	Necrosis 02/2024 - 11/2018
2	Neoplasms (Cancer) 09/2022 - 09/2017
2	Peritonitis 01/2021 - 08/2005
2	Persistent Infection 01/2020 - 01/2018
2	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2020 - 10/2019
2	Disease Progression 01/2020 - 10/2019
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Dysbiosis 01/2023
1	Cross Infection (Nosocomial Infection) 10/2022
1	Osteoporosis 09/2022
1	Arthritis (Polyarthritis) 09/2022
1	Starvation 01/2022
1	Brain Neoplasms (Brain Tumor) 12/2021
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2021
1	Metrorrhagia (Spotting) 03/2021
1	Critical Illness (Critically Ill) 03/2021
1	Nontuberculous Mycobacterium Infections 01/2021
1	Liver Abscess 01/2021
1	Ototoxicity 01/2021
1	Breakthrough Infections 01/2021
1	Candidiasis (Moniliasis) 01/2020
1	Invasive Candidiasis 01/2020

Drug/Important Bio-Agent (IBA)

23	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 08/2005
14	Rifampin (Rifampicin)FDA LinkGeneric 05/2024 - 05/2010
10	Pyrazinamide FDA LinkGeneric 01/2023 - 01/2012
7	Isoniazid (Ftivazide)FDA LinkGeneric 01/2023 - 05/2010
7	LipidsIBA 11/2021 - 01/2012
6	Moxifloxacin (Avelox)FDA Link 01/2023 - 03/2011
4	RifamycinsIBA 09/2023 - 01/2019
4	Linezolid (Zyvox)FDA Link 01/2023 - 11/2015
4	EnzymesIBA 10/2019 - 08/2011
3	Antimicrobial PeptidesIBA 04/2024 - 08/2005
3	Oxygen (Dioxygen)IBA 02/2024 - 01/2022
3	LactamsIBA 12/2023 - 01/2022
3	FluoroquinolonesIBA 11/2021 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	Levofloxacin (Levaquin)FDA Link 01/2019 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2016
3	pyrazinoic acidIBA 11/2017 - 01/2016
2	Oxazolidinones (2 Oxazolidone)IBA 01/2023 - 01/2016
2	CholesterolIBA 12/2022 - 01/2018
2	Vancomycin FDA LinkGeneric 03/2021 - 01/2021
2	Kanamycin FDA Link 03/2021 - 01/2021
2	Streptomycin (Streptomycin Sulfate)FDA Link 03/2021 - 01/2021
2	Amikacin (A.M.K)FDA LinkGeneric 03/2021 - 01/2021
2	AminoglycosidesIBA 03/2021 - 01/2021
2	Methicillin (Metin)FDA Link 01/2021 - 08/2005
2	EchinocandinsIBA 01/2021 - 10/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2016
2	Gatifloxacin (Zymar)FDA Link 01/2019 - 08/2017
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2018 - 01/2017
2	Allopurinol (Remid)FDA LinkGeneric 10/2017 - 05/2015
2	Xanthine OxidaseIBA 10/2017 - 05/2015
1	Bevacizumab (Avastin)FDA Link 04/2024
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Losartan (Cozaar)FDA LinkGeneric 04/2024
1	AcidsIBA 12/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2023
1	VaccinesIBA 11/2023
1	Alkali MetalsIBA 02/2023
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2023
1	tebipenemIBA 01/2023
1	PNU-100480IBA 01/2023
1	avibactamIBA 01/2023
1	tedizolidIBA 01/2023
1	Protein Synthesis InhibitorsIBA 01/2023
1	phenylalanine amideIBA 12/2022
1	MMV688845IBA 12/2022
1	CarbonIBA 12/2022
1	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2022
1	DepsipeptidesIBA 01/2022
1	MacrolidesIBA 01/2022
1	griselimycinIBA 01/2022
1	Cefotaxime (Kendrick)FDA LinkGeneric 12/2021
1	Topoisomerase II InhibitorsIBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	macozinoneIBA 10/2021
1	quinolineIBA 01/2021
1	APX001AIBA 01/2021
1	ginger extractIBA 01/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	TBAJ-876IBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020

Therapy/Procedure

11	Therapeutics 04/2024 - 05/2015
9	Drug Therapy (Chemotherapy) 04/2024 - 05/2010
6	Duration of Therapy 01/2023 - 07/2015
4	Lasers (Laser) 01/2021 - 10/2015
1	Oral Administration 01/2023
1	Injections 01/2021